Lantern Pharma Launches Innovative AI-Powered Module to Advance ADC Development for Cancer
The global ADC market is projected to reach USD 30.4 billion by 2028, growing at a CAGR of 41.7 percent, with several recently approved ADCs achieving blockbuster status with annual sales exceeding USD 1 billion.
Pharmaceutical Companies | 28/01/2025 | By Aishwarya
Granules India Unit V Facility Completes US FDA Inspection with Zero 483 Observations
Granules India Ltd. has announced that the company’s Unit V facility has completed the US Food and Drug Administration (FDA) inspection between April 8-12, 2024, resulting in zero 483 observations.
Pharmaceutical Companies | 15/04/2024 | By Aishwarya | 421
New Toolkit Supports Digital Endpoints in Drug Development
DiMe, Biogen, Eli Lilly, Pfizer, and other top pharma companies launched a toolkit to ensure that organizations develop digital endpoint evidence in an acceptable way during drug development.
Pharmaceutical Companies | 12/04/2022 | By Sudeep Soparkar | 288
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy